Bharat Immunologicals and Biologicals Corporation Ltd 524663.BO

₹17.37

Last Updated: May 15, 12:00 AM·BSE

524663.BO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 06, 2024

Report Source: 2024 2nd Quarter Report

Bharat Immunologicals and Biologicals Corporation Ltd

Bharat Immunologicals and Biologicals Corporation Ltd. Stock Analysis 524663.BO

India Health Care Nano Cap Report:
Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. The firm is primarily engaged in the manufacture of oral polio vaccine, zinc tablet, and diarrhea management kit. The company operates under various segment, namely oral polio vaccine, zinc tablets, BIB VIT, and BIBSANIT. The company is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The firm is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). The company is also diversified into plasma-derived medicines and Oral Cholera vaccines. The firm's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.
Read More

Bharat Immunologicals and Biologicals Corporation Ltd (524663.BO) Chart

Key Statistics of Bharat Immunologicals and Biologicals Corporation Ltd (524663.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹17.37₹17.94

Today's Open

₹17.37

Volume

16.16K

P/E Ratio (TTM)

-

52 Week Range

₹14.10₹28.80

Market Cap

729.13M

Avg. Volume

44.73K

Dividend Yield

-

Financial Metrics & Statements of Bharat Immunologicals and Biologicals Corporation Ltd (524663.BO)

FAQ's for Bharat Immunologicals and Biologicals Corporation Ltd (524663.BO)

  • According to Musaffa’s Shariah screening methodology, Bharat Immunologicals and Biologicals Corporation Ltd (524663.BO) is currently classified as NOT HALAL as of April 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.